In order to protect patients and users of certain products, it is necessary to design study to assess the interaction between the released or migrated components into the pharmaceutical product and the possible health risk to the user.

Read More

Nitrosamines represent one of the first risks of contamination in pharmaceutical products and basic active ingredients: listed as carcinogenic mutagens, nitrosamines can be tolerated when complying to...

Read More

Starting from 27th of March 2021 Reg. EU No. 1381/2019 – Transparency Regulation influences all applications for Regulated Products authorization, including food and feed additives, novel foods, food enzymes, flavorings and GMOs.

Read More

An analysis conducted on the risk assessment allows companies and administrations to meet the increasingly high standards of safety in the FCM context. Indeed, food contact materials are subject ...

Read More

Medicines must be tested for the presence of nitrosamines before being released into the European Market, stated European Medicines Agency (EMA). LabAnalysis has developed a method for the determinat...

Read More
News 24 Dicembre 2020

Welfare Champion 2020

We are proud to be one of the 78 companies that have been awarded Welfare Champion 2020 by WelfareIndexPMI for the enhancement of the well-being of our employees. The event was promoted by Genera...

Read More

Versalis, the chemical company of Eni Energies & Services, has distributed the hand sanitizer in all the Italian schools, to meet the growing demand caused by the current health situation. The pro...

Read More